Details of the Drug | DrugMAP

General Information of Drug (ID: DMDXZ6O)

Drug Name

ALK-001

Indication

Disease Entry	ICD 11	Status	REF
Age-related macular degeneration	9B75.0	Phase 2	[1]
Stargardt disease	9B70	Phase 2	[2]
------------------------------------------------------------------------------------

Structure

3D MOL

2D MOL

Chemical Identifiers

Formula: C22H32O2
Canonical SMILES: CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CCOC(=O)C)C)C
InChI: 1S/C22H32O2/c1-17(9-7-10-18(2)14-16-24-20(4)23)12-13-21-19(3)11-8-15-22(21,5)6/h7,9-10,12-14H,8,11,15-16H2,1-6H3/b10-7+,13-12+,17-9+,18-14+/i2D3
InChIKey: QGNJRVVDBSJHIZ-QJZZLBIKSA-N

Cross-matching ID

PubChem CID: 126843217
TTD ID: D0B9RD

Repurposed Drugs (RPD)

Click to Jump to the Detailed RPD Information of This Drug

References

1	ClinicalTrials.gov (NCT02402660) Tolerability and Effects of ALK-001 on Stargardt Disease. U.S. National Institutes of Health.
2	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)